2/15
08:32 am
glue
Rating for GLUE
High
Report
Rating for GLUE
2/15
08:32 am
glue
Rating for GLUE
High
Report
Rating for GLUE
2/15
07:17 am
glue
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock.
High
Report
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock.
2/15
07:17 am
glue
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock.
High
Report
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock.
2/14
04:04 pm
glue
Monte Rosa Therapeutics initiated with bullish view at Wedbush
High
Report
Monte Rosa Therapeutics initiated with bullish view at Wedbush
2/14
04:04 pm
glue
Monte Rosa Therapeutics initiated with bullish view at Wedbush
High
Report
Monte Rosa Therapeutics initiated with bullish view at Wedbush